Every dental AI sales-enablement team that adopted the "Competitor A or Competitor B" battlecard convention in 2026 ran into the same coordination problem inside the first quarter: which slot does Voicify go in for this deal? The convention is portable — that is the point of it — but portability is only useful if the rep can decide the slot mechanically before the first call. Otherwise the team ends up with two Voicify cards, both technically correct, and the rep grabs whichever one was open in their last tab. This post is the decision framework we walk dental AI go-to-market teams through: five signals from the deal that decide whether Voicify belongs in the A slot or the B slot, before the rep dials.
TL;DR
The deal decides the slot, not the rep. Voicify lands in the Competitor A slot — incumbent being displaced — when the prospect already has Voicify in production. Voicify lands in the Competitor B slot — challenger pitching a switch — when the prospect has a dental-pure incumbent and Voicify is the new pitch. Five signals decide the slot: incumbency, renewal proximity, staff training status, CFO budget status, and the dental-pure vendor on the other side. Build the decision tree once, codify it in the discovery brief, and the slot assignment becomes mechanical instead of intuitive.
Key Takeaways
- A-slot = displacement play — used when Voicify is the incumbent already running in production at one or more locations with certified PMS write-back.
- B-slot = challenger pitch — used when Voicify is the new vendor pitching a switch against a dental-pure incumbent like Arini, Yenza, or Peerlogic.
- Five signals decide the slot: production status, renewal proximity (under 9 months), staff training status, CFO budget approval, and the dental-pure vendor on the other side.
- Slot assignment lives in the discovery brief, not the rep's head — the sales-enablement lead assigns the slot before the call so the rep walks in with the correct card pulled.
- Wrong-slot openings cost a full deal cycle — a displacement card against a non-deployed prospect reads as presumptuous; a defense card against an unstable rollout reads as evasive.
Why the Slot Decision Belongs Upstream of the Rep
The most common failure mode in a dental AI battlecard library is not card quality — it is slot assignment. We have watched senior reps with great Voicify cards open a discovery call with the displacement framing when the prospect was not actually running Voicify yet, and watched the call go sideways inside ninety seconds. The reverse — defense framing on a deal where Voicify was already churning out the back door — is just as costly. The slot decision has to be made in the discovery brief, not in the rep's head while they are walking into the conference room. That means the sales-enablement lead is responsible for the slot assignment, and the rep is responsible for the play. For the underlying card structure both slots reference, see our Voicify "Competitor A or B" side-by-side walkthrough and the Voicify-worked battlecard template.
Signal 1: Incumbency — Is Voicify in Production Today?
This is the load-bearing signal and the easiest one to get wrong. "In production" does not mean "signed contract." It means call traffic is hitting the Voicify endpoint and the PMS write-back is certified at one or more locations. A signed contract with Voicify in a six-month rollout window is still a B-slot deal until first location cleared go-live. The reverse is also true: a Voicify deployment that has cleared one location but not the other 39 is still an A-slot deal — the rep should not pretend the 39 are running just because contract paper says so.
| Signal 1: Incumbency | A-slot indicator | B-slot indicator |
|---|---|---|
| Production status | Voicify has cleared go-live at one or more locations and PMS write-back is certified | Voicify is not in production at any location, regardless of contract status |
| Call traffic | Real call volume hitting the Voicify endpoint for at least 30 days | Zero call volume to Voicify; current capture handled by hosted answering service, in-house, or the dental-pure incumbent |
Signal 2: Renewal Proximity
The second signal is whether the Voicify renewal date is inside the deal window. A-slot plays only work if the rep can plausibly land before the next renewal — otherwise the prospect cannot act on the displacement narrative without paying twice. If the renewal is more than nine months out, the A-slot play converts to long-cycle nurture and the card the rep actually carries to the call is a renewal-minus-90 pre-arm, not a displacement card.
| Signal 2: Renewal proximity | A-slot indicator | B-slot indicator |
|---|---|---|
| Renewal window | Voicify renewal inside next 9 months — full displacement play | Not applicable — B slot deals do not have a Voicify renewal date yet |
| Long-cycle handling | Voicify renewal beyond 9 months — convert to nurture, re-engage at renewal minus 90 days | Not applicable |
Signal 3: Staff Training Status of the Last Rollout
Whether the last AI receptionist rollout cleared staff training across the prospect's locations is the cleanest predictor of how willing the prospect is to absorb a switch. A DSO that just cleared training across 40 locations in the last 90 days will not switch on price alone — the displacement card has to lead with a dated, written product gap, not a TCO calculator. A DSO that is still mid-training has switch cost still in motion and the displacement card can be more aggressive about reframing the in-flight investment.
| Signal 3: Training status | A-slot indicator | B-slot indicator |
|---|---|---|
| Just cleared | Training cleared in last 90 days — displacement card must lead with dated product gap, not TCO | Not applicable — B-slot prospect has not deployed Voicify yet |
| Mid-training | Training still in motion — displacement card can frame in-flight investment as switchable | Not applicable |
Signal 4: CFO Budget Status
The fourth signal is whether the CFO has already approved the Voicify spend in the current fiscal year budget. If the CFO has signed on the spend and the renewal is inside the deal window, the rep is running a displacement play against a budget line the prospect's finance team has not yet absorbed as sunk cost. If the CFO has not signed and the deal is still pre-evaluation, the slot is B and the rep is running a challenger pitch.
| Signal 4: CFO budget | A-slot indicator | B-slot indicator |
|---|---|---|
| Spend approved | CFO signed on Voicify spend in current FY — full displacement play, lead with TCO and switch cost | Not applicable |
| Spend pending | Not applicable — pending spend usually means Voicify is not yet incumbent | CFO has not signed on Voicify — B slot, run challenger pitch |
Signal 5: The Dental-Pure Vendor on the Other Side
The fifth signal does not change the slot, but it does change the trap-setters and proof points the card brings. If the dental-pure opponent on the other side is Arini, Yenza, Annie, Peerlogic, or Adit Voice, the displacement-vs-defense framing holds — but the specific gaps the trap-setters surface differ by vendor. The slot decision tree should run first, then the dental-pure opponent slot in the shared appendix decides the trap content.
| Signal 5: Dental-pure opponent | Effect on slot | Effect on trap-setters |
|---|---|---|
| Arini, Yenza, Annie, Peerlogic, Adit Voice | None — slot is decided by signals 1–4 | Re-spec trap-setters per opponent based on integration depth and implementation timeline data in the shared appendix |
The Slot Decision Tree, Rendered Once
Put the five signals in order and the slot assignment falls out mechanically. The decision tree below is the one we walk dental AI go-to-market teams through during the battlecard sprint. It runs in under two minutes per deal and the output goes directly into the rep's discovery brief.
- Signal 1 — Incumbency. Is Voicify in production at one or more locations with certified PMS write-back? If yes, slot = A. If no, slot = B. Stop here for B-slot deals; signals 2–4 do not apply.
- Signal 2 — Renewal proximity (A-slot only). Is the Voicify renewal inside the next 9 months? If yes, full displacement play. If no, convert to renewal-minus-90 nurture.
- Signal 3 — Training status (A-slot only). Did the Voicify rollout clear staff training in the last 90 days? If yes, lead with dated product gap. If still mid-training, lead with reframed in-flight investment.
- Signal 4 — CFO budget (A-slot only). Has the CFO signed on the Voicify spend in the current FY? If yes, lead with TCO and switch cost. If no, the deal is probably mis-slotted — return to Signal 1.
- Signal 5 — Dental-pure opponent (both slots). Pull the opponent's row from the shared appendix and re-spec trap-setters and proof points.
What Goes in the Discovery Brief
The output of the decision tree belongs in the discovery brief the rep reads before the call, not in the rep's head. A clean brief has five fields filled in — the five signal answers — plus the resulting slot assignment, plus the dental-pure opponent name. Reps are not expected to re-run the decision tree mid-call. They are expected to walk in with the slot already assigned and the card already pulled. For the broader operational playbook on running this kind of slot-assignment discipline at scale, see our naming convention rulebook and the battlecard decoder for buyers on the other side of these cards.